icd 10 glp 1 use Predicting responsiveness to GLP-1 pathway drugs using real-world data | BMC Endocrine Disorders ICD-10 Code Z79.4: Long-Term Use

Medication Impact / Treatment Pharmacotherapy for obesity has undergone a paradigm shift with the approval and widespread adoption of GLP-1 receptor agonists

We aimed to assess the relationship between GLP-1s and osteoporosis likelihood across different amounts of weight change among patients with and without diabetes

BMI codes and other categories of Z codes (Z68, Z86.3 etc.) may be used as a secondary code when the associated diagnosis is documented. A BMI reported by a nutritionist or registered nurse may be used if the diagnosis of obesity, overweight, or underweight is documented by the responsible physician

GLP-1s are generally well tolerated, with most gastrointestinal side effects subsiding over time

Persistent or severe diarrhoea warrants assessment for dehydration and electrolyte disturbances, particularly in elderly patients or those with comorbidities

If you get diabetes, you will need to take medications and monitor blood sugar